Alain Faivre-Chauvet Selected Research

DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amide

1/2021	Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.
6/2018	Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT.
1/2015	Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alain Faivre-Chauvet Research Topics

Disease

38	Neoplasms (Cancer) 10/2023 - 02/2002
11	Multiple Myeloma 06/2023 - 02/2002
7	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 05/2005
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2011
4	medullary Thyroid cancer 06/2012 - 02/2002
3	Carcinoma (Carcinomatosis) 06/2018 - 02/2011
2	Colonic Neoplasms (Colon Cancer) 06/2018 - 02/2011
2	Hematologic Diseases (Blood Diseases) 02/2015 - 01/2012
2	Colorectal Neoplasms (Colorectal Cancer) 12/2011 - 02/2011
1	Infections 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Sarcoma (Soft Tissue Sarcoma) 06/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021
1	Leukemia 03/2016
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Peritoneal Neoplasms 01/2015
1	Neoplasm Micrometastasis 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2014
1	Adenocarcinoma 04/2014
1	Lymphoma (Lymphomas) 01/2012
1	Breast Neoplasms (Breast Cancer) 09/2011
1	Triple Negative Breast Neoplasms 09/2011
1	Hypoxia (Hypoxemia) 01/2011
1	Leukopenia 04/2010

Drug/Important Bio-Agent (IBA)

13	Monoclonal AntibodiesIBA 01/2021 - 02/2002
10	Carcinoembryonic AntigenIBA 01/2021 - 09/2003
8	AntigensIBA 01/2019 - 02/2002
7	Peptides (Polypeptides)IBA 01/2021 - 12/2011
7	Radioisotopes (Radionuclides)IBA 11/2020 - 01/2011
6	AntibodiesIBA 05/2019 - 02/2011
6	HaptensIBA 01/2015 - 02/2002
5	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 08/2012 - 02/2002
4	RadiopharmaceuticalsIBA 01/2020 - 01/2011
4	Bismuth-213IBA 02/2015 - 02/2002
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2021 - 01/2019
3	AcidsIBA 01/2021 - 02/2002
3	Chelating AgentsIBA 01/2021 - 02/2002
3	DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA 01/2021 - 01/2015
3	Immunoglobulin G (IgG)IBA 01/2019 - 01/2018
3	Immunoconjugates (Immunoconjugate)IBA 01/2017 - 10/2014
3	IndiumIBA 01/2015 - 02/2002
3	Pentetic Acid (DTPA)FDA LinkGeneric 01/2015 - 02/2002
3	Liposomes (Liposome)IBA 01/2015 - 01/2006
2	Copper-64IBA 06/2023 - 02/2015
2	LigandsIBA 01/2019 - 01/2018
2	LuciferasesIBA 06/2018 - 02/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018 - 02/2018
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 08/2012
2	Lutetium-177IBA 02/2015 - 01/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2015 - 02/2011
2	IodineIBA 10/2014 - 01/2006
2	AstatineIBA 10/2014 - 01/2006
2	Complement System Proteins (Complement)IBA 04/2014 - 09/2007
2	Syndecan-1 (Syndecan 1)IBA 06/2012 - 09/2011
2	Iodine-131IBA 02/2010 - 02/2002
1	68Ga-pentixaforIBA 10/2023
1	68Ga-DOTANOCIBA 03/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	n-dodecaneIBA 01/2021
1	Dihydroxyphenylalanine (Dopa)IBA 01/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2019
1	tetraethylpyrazine (TEP)IBA 01/2019
1	cyclamIBA 01/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2018
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	CD66 antigensIBA 03/2016
1	Gallium-68IBA 02/2015
1	Zirconium-89IBA 02/2015
1	Iodine-124IBA 02/2015
1	Astatine-211IBA 02/2015
1	Copper-67IBA 02/2015
1	Fluorine-18IBA 02/2015
1	Actinium-225IBA 02/2015
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 01/2015
1	AvidinIBA 01/2015
1	Biotin (Vitamin H)FDA Link 01/2015
1	Culture MediaIBA 01/2015
1	LipidsIBA 01/2015
1	Bispecific AntibodiesIBA 01/2015
1	BismuthIBA 10/2014
1	CD20 AntigensIBA 10/2014
1	LutetiumIBA 10/2014
1	YttriumIBA 10/2014
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 06/2012
1	procaine isothiocyanate (PRIT)IBA 12/2011
1	Hormones (Hormone)IBA 09/2011
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 01/2011
1	fluoromisonidazoleIBA 01/2011

Therapy/Procedure

20	Radioimmunotherapy 03/2016 - 02/2002
14	Therapeutics 11/2021 - 02/2002
5	Precision Medicine 06/2023 - 02/2015
4	Immunotherapy 01/2020 - 09/2007
2	Aftercare (After-Treatment) 09/2011 - 02/2002
1	Cytoreduction Surgical Procedures 01/2015
1	Hyperthermic Intraperitoneal Chemotherapy 01/2015
1	Injections 01/2015
1	Radiotherapy 01/2015
1	Induction Chemotherapy 10/2014